SCHEMBL7933667

SCHEMBL7933667

CCOC(=O)C(Cl)=Cc1cc(N(C=O)OCC)ccc1Cl

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.34
TSHR P16473 1/20 0.34
MAPT P10636 6/20 0.33
ALDH1A1 P00352 3/20 0.33
HPGD P15428 2/20 0.33
LMNA P02545 2/20 0.33
ABCB1 P08183 1/20 0.33
POLB P06746 1/20 0.33
RAB9A P51151 1/20 0.33
GAA P10253 3/20 0.33
KMT2A Q03164 3/20 0.33
ATM Q13315 1/20 0.33
GPR35 Q9HC97 2/20 0.33
MEN1 O00255 1/20 0.33
TDP1 Q9NUW8 2/20 0.32
KDM4E B2RXH2 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
MIF P14174 1/20 0.32
CYP4F2 P78329 1/20 0.32
CYP4A11 Q02928 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7089765 0.76 LMNA (0.40) SMN1; SMN2TSHRMAPTALDH1A1HPGD
SCHEMBL7018839 0.76 LMNA (0.40) SMN1; SMN2TSHRMAPTALDH1A1HPGD
SCHEMBL7929225 0.76 MAPK1 (0.43) SMN1; SMN2TSHRMAPTALDH1A1HPGD
SCHEMBL7929230 0.76 MAPK1 (0.43) SMN1; SMN2TSHRMAPTALDH1A1HPGD
SCHEMBL7017572 0.76 MAPT (0.41) SMN1; SMN2TSHRMAPTALDH1A1HPGD
SCHEMBL7020494 0.76 MAPT (0.41) SMN1; SMN2TSHRMAPTALDH1A1HPGD
SCHEMBL7933665 0.75 DGAT1 (0.48) SMN1; SMN2MAPTALDH1A1HPGDLMNA
SCHEMBL7933664 0.75 DGAT1 (0.48) SMN1; SMN2MAPTALDH1A1HPGDLMNA
SCHEMBL7931186 0.74 KMT2A (0.42) SMN1; SMN2MAPTALDH1A1HPGDRAB9A
SCHEMBL7931184 0.74 KMT2A (0.42) SMN1; SMN2MAPTALDH1A1HPGDRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20010031865-A1 Substituted 3-phenyluracils KLINTZ RALF (DE) 2001-10-18 US disclosed
US-6239074-B1 HERBICIDES, INSECTICIDES BASF AKTIENGESELLSCHAFT (DE) 2001-05-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010031865-A1 Substituted 3-phenyluracils CCR1, CCR6, CCR3 SMN1; SMN2 4165/4885TSHR 1263/4885MAPT 4647/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.